BioSpace News Archive

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell therapies for neurodegenerative diseases, announced the presentation of a poster titled, “MSC-NTF Exosomes: A Novel Therapeutic Modality in the Mouse LPS-induced ARDS model Analysis” at the NYSCF Conference Meeting, being held virtually.

Financing will advance its musculoskeletal product through a clinical proof of activity trial as well as continue the discovery and development of its ongoing pipeline of microbial-based products for human health and well-being.

EXUMA Biotech Corporation, a clinical-stage biotechnology company discovering and developing CAR-T products and delivery solutions for liquid and solid tumors, is pleased to announce that Dr. Sid Kerkar, M.D., has joined the company’s senior leadership team as Vice President Oncology, Research & Development effective September 2020.

Notch Therapeutics Inc., a cell therapy company with a proprietary platform for generating renewable stem cell-derived T cell therapies for cancer and other immune disorders, announced today the appointment of Kamran Alam as Executive Vice President, Finance and Chief Financial Officer and Gregory Block as Senior Vice President, Corpo

Delaying surgery for 12 months or more after a rotator cuff tear diagnosis is associated with almost twice the odds of needing a subsequent revision surgery compared to having surgery between six weeks and one year after diagnosis, according to a retrospective study of records from thousands of patients across the United States by investigators at Hospital for Special Surgery.

Kibow Biotech, a pioneering innovator in scientifically formulated and clinically tested probiotic dietary supplements, internationally renowned for its kidney health supplements Renady l ™ and Azodyl ®, announced today that it has released Kibow Cardio Support ™ for sale to the general public in celebration of i

NTT Research, Inc., a division of NTT, announced that Dr. Yoshihisa Yamamoto, the Director of its Physics and Informatics Lab, along with colleagues at several academic institutions, has proposed an interdisciplinary research agenda that amounts to a new field of academic study.

DRE is pleased to welcome four new members to its MSAB. They join Chair, Ameet Nathwani, MD, MRCP, DipPharmMed, MBA in advising DRE on the convergence of expert AI-enabled technology in healthcare and the exponential growth of clinical information.

Inaugural Hearing Health & Technology Matters Awards Recognize SYNCHRONY Cochlear Implant System, BONEBRIDGE Bone Conduction Implant and AudioKey App for Innovation Excellence

Octapharma is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved an updated Prescribing Information (PI) for NUWIQ®, Octapharma’s human cell line-derived recombinant factor VIII (FVIII). NUWIQ ® is approved for the prevention and treatment of bleeding in people with haemophilia A.